Kurt A Jellinger Selected Research

Pallidopyramidal syndrome

1/2022

Pallidal degenerations and related disorders: an update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kurt A Jellinger Research Topics

Disease

22	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 07/2002
21	Parkinson Disease (Parkinson's Disease) 09/2021 - 09/2003
18	Multiple System Atrophy 03/2022 - 08/2003
17	Dementia (Dementias) 01/2022 - 09/2003
15	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 01/2008
13	Synucleinopathies 03/2022 - 09/2003
13	Proteostasis Deficiencies 01/2022 - 09/2003
10	Cognitive Dysfunction 01/2022 - 12/2004
8	Neuroinflammatory Diseases 01/2022 - 05/2011
7	Atrophy 01/2022 - 05/2012
7	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 09/2009
5	Parkinsonian Disorders (Parkinsonism) 03/2022 - 02/2005
4	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022 - 04/2004
4	Tauopathies 01/2019 - 09/2006
4	Lewy Body Disease (Lewy Body Dementia) 01/2018 - 07/2009
3	Amyloid Plaque 01/2022 - 01/2009
3	Gliosis 01/2022 - 08/2005
3	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 01/2019 - 09/2003
3	Disease Progression 08/2014 - 08/2005
3	Schizophrenia (Dementia Praecox) 05/2011 - 11/2002
3	Movement Disorders (Movement Disorder) 03/2010 - 09/2003
3	Striatonigral Degeneration 02/2005 - 08/2003
2	Inflammation (Inflammations) 01/2022 - 05/2012
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 09/2021 - 06/2012
2	Hepatolenticular Degeneration (Wilson's Disease) 01/2019 - 01/2019
2	Huntington Disease (Huntington's Disease) 01/2019 - 01/2019
2	Brain Diseases (Brain Disorder) 05/2012 - 05/2011
2	Encephalitis (Encephalitis, Rasmussen) 05/2012 - 09/2009
1	Basal Ganglia Diseases (Basal Ganglia Disease) 03/2022
1	Kufor-Rakeb syndrome 01/2022
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2022
1	Muscle Spasticity (Spastic) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Cerebral Small Vessel Diseases 01/2022
1	Neuroferritinopathy 01/2022
1	Pallidopyramidal syndrome 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 12/2021
1	Vascular Depression 12/2021
1	Communicable Diseases (Infectious Diseases) 08/2021
1	Hippocampal Sclerosis 01/2020
1	Pick Disease of the Brain (Pick's Disease) 01/2019
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2019
1	Corticobasal Degeneration 01/2019
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2019
1	Insulin Resistance 11/2017
1	Prodromal Symptoms 10/2015
1	Anosmia 04/2014

Drug/Important Bio-Agent (IBA)

18	SynucleinsIBA 03/2022 - 01/2009
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
16	alpha-SynucleinIBA 06/2010 - 09/2003
12	Biomarkers (Surrogate Marker)IBA 03/2022 - 08/2008
9	Amyloid (Amyloid Fibrils)IBA 01/2022 - 09/2006
8	Amyloid beta-PeptidesIBA 05/2008 - 01/2004
7	Peptides (Polypeptides)IBA 05/2011 - 01/2004
4	Cholinergic Agents (Cholinergics)IBA 01/2022 - 12/2012
4	PrionsIBA 09/2021 - 06/2012
4	UbiquitinIBA 06/2010 - 01/2008
3	polyglutamineIBA 01/2022 - 01/2019
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 08/2009
3	Pharmaceutical PreparationsIBA 10/2019 - 04/2014
3	Nerve Growth Factors (Neurotrophins)IBA 01/2018 - 09/2009
3	tau Proteins (tau Protein)IBA 04/2014 - 01/2008
3	Free RadicalsIBA 01/2013 - 09/2009
2	Levodopa (L Dopa)FDA LinkGeneric 03/2022 - 02/2005
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 08/2009
2	Protein AggregatesIBA 01/2022 - 01/2011
2	LipidsIBA 01/2018 - 01/2016
2	IronIBA 01/2018 - 09/2003
2	Neuroprotective AgentsIBA 08/2015 - 02/2005
2	Chromogranin AIBA 05/2011 - 01/2004
2	ChromograninsIBA 05/2011 - 01/2004
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2011 - 08/2009
2	LY 165163 (PAPP)IBA 06/2010 - 09/2003
2	CaspasesIBA 09/2006 - 02/2005
2	Chromogranin BIBA 01/2004 - 11/2002
1	1-dodecylpyridoxal (PLD)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	ParaffinIBA 08/2021
1	Formaldehyde (Formol)FDA Link 08/2021
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 12/2019
1	Biological ProductsIBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2018
1	Insulin (Novolin)FDA Link 11/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Neurofilament ProteinsIBA 04/2014
1	ZincIBA 01/2013
1	Chelating AgentsIBA 01/2013
1	ManganeseIBA 01/2013
1	MetalsIBA 01/2013
1	AluminumIBA 01/2013
1	CopperIBA 01/2013
1	AntibodiesIBA 05/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2012
1	Surface Antigens (Surface Antigen)IBA 05/2012
1	AntigensIBA 05/2012
1	Complement System Proteins (Complement)IBA 05/2012
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 05/2012
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 05/2012

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2013
1	Secondary Prevention 08/2015